Christopher Fullerton
Follow
Get notifications in MyBN when activity occurs.
Christopher Fullerton
Non-Executive Director / XTEK
Christopher Fullerton has experience in investment, management and investment banking. He is an investor in listed equities and private equity, and his current unlisted company directorships cover companies in the property investment and agriculture sectors.
Mr Fullerton's exposure to and experience in the fields of biotechnology and health care technology was gained through his role as non-executive chair of Bionomics, Cordlife and Health Communication Network.
Mr Fullerton's exposure to and experience in the fields of biotechnology and health care technology was gained through his role as non-executive chair of Bionomics, Cordlife and Health Communication Network.
Lists and Charts
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 477th |  | XTEK | $89.5m |
| 562nd | | Djerriwarrh Investments | $50.7m |
| 563rd | | Elanor Commercial Property Fund | $50.6m |
| 565th | | Velocity Property Group | $49.7m |
| 566th |  | Buddy Technologies | $49.6m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, XTEK | 13 Nov 2020 |
| NEW ROLE: Non-Executive Director, XTEK | 03 Nov 2020 |
| NEW ROLE: Non-Executive Director, Paradigm Biopharmaceuticals | 03 Nov 2020 |
